Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lemborexant for Sleep Promotion and Delirium Prevention in Critically Ill Adults
NCT07407400Phase 4Recruiting
- Sponsor
- Mahidol University
- Start
- Sep 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lemborexant in sleep disorder, delirium, sponsored by Mahidol University. Started Sep 2026; status: recruiting.
02
Drugs
lemborexant
03
Conditions
sleep disorderdelirium
Beyond the preview
Go deeper on NCT07407400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07407400.